About Us
Overview
Mission and Vision
Board of Directors
Awards & Recognitions
Business Areas
Overview
India - Branded Generics
Emerging Markets - Branded Generics
USA - Generics
Manufacturing
Overview
Manufacturing Facilities
Quality
Sustainability
R&D
Investors
Financials
Corporate Governance
Investor Information
Media
Press Release
Media Coverage
Media Kit
Career
Life at Ajanta
Work with Us
CSR
Contact Us
Search
Statutory Communications 2022-23 | Ajanta Pharma Investors
Financials
Home
-
Investors
Financials
Quarterly Results
2026-27
2025-26
2024-25
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
2014-15
Q4
(Jan – Mar)
Q4 FY2023
Earnings Call Transcript
Q4 FY2023
Press Release
Q4 FY2023
Earnings Call Audio
Q4 FY2023
Investor Presentation
Q3
(Oct – Dec)
Q3 FY2023
Earnings Call Transcript
FY2023
Investor Presentation
Q3 FY2023
Earnings Call Audio
Q3 FY2023
Investor Presentation
Q3 FY2023
Press Release
Q2
(Jul – Sep)
Q2 FY2023
Earnings Call Transcript
Q2 FY2023
Earnings Call Audio
Q2 FY2023
Investor Presentation
Q2 FY2023
Press Release
Q1
(Apr – Jun)
Q1 FY2023
Earnings Call Audio
Q1 FY2023
Investor Presentation
Q1 FY2023
Press Release
Q1 FY2023
Earnings Call Transcript
Related Links
Overview
Quarterly Results
Annual Reports
